Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
This study is ongoing, but not recruiting participants.
Study NCT00948961   Information provided by Celldex Therapeutics

First Received on July 28, 2009.   Last Updated on May 31, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Malignancies
Additional conditions recognized in this trial
Neoplasms
Additional drug interventions recognized in this trial
Poly ICLC
More general drug interventions related to this trial
Immunologic Factors
Interferon Inducers
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Celldex Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services